Search Health Topics
Search the NIH Guide
August 5, 2020
Dr. Collins talks to CBS’ Jonathan LaPook about the launch of ACTIV-2 and ACTIV-3 inpatient and outpatient clinical trials to test effectiveness of monoclonal antibody treatment for COVID-19.
This page last reviewed on August 6, 2020